Health

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

June 16, 2025 19:20 ET  | Source: PolyPid Ltd. The Company Anticipates that with this Additional Funding, PolyPid’s Runway would…

GlobeNews Wire

DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting

November 24, 2025 02:00 ET  | Source: DXS International PLC Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of…

GlobeNews Wire

Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026

Zurich, June 19, 2025 (GLOBE NEWSWIRE) -- Superlab Suisse has announced the opening of its fourth Swiss laboratory facility at…

GlobeNews Wire
- Advertisement -
Latest Health News

Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…

GlobeNews Wire

Genesis Healthcare Remains Committed to Securing Longterm Stability

KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…

GlobeNews Wire

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

December 11, 2025 18:25 ET  | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…

GlobeNews Wire

Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

Media Release Event to be held virtually via live webcast and archived…

GlobeNews Wire

Aukera Therapeutics Comes Out of Stealth

BASEL, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Aukera Therapeutics, a preclinical-stage…

GlobeNews Wire